|
MAP4K5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.375800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.994300E-02 |
| Normal-vs-Stage2 |
8.915000E-01 |
| Normal-vs-Stage3 |
6.721800E-01 |
| Normal-vs-Stage4 |
4.568600E-01 |
| Stage1-vs-Stage2 |
3.012400E-01 |
| Stage1-vs-Stage3 |
3.478100E-02 |
| Stage1-vs-Stage4 |
2.247900E-02 |
| Stage2-vs-Stage3 |
6.511600E-01 |
| Stage2-vs-Stage4 |
4.823000E-01 |
| Stage3-vs-Stage4 |
7.348800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.372400E-01 |
| Normal-vs-AfricanAmerican |
4.251400E-01 |
| Normal-vs-Asian |
3.914800E-01 |
| Caucasian-vs-AfricanAmerican |
5.966800E-01 |
| Caucasian-vs-Asian |
5.956000E-01 |
| AfricanAmerican-vs-Asian |
7.422400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.375600E-01 |
| Normal-vs-Female |
1.643960E-01 |
| Male-vs-Female |
1.065970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.726600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.404400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.313600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.018200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.866200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.958000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.799400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.127400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.080030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.956580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.923040E-03 |
| Normal-vs-Grade 2 |
1.046030E-02 |
| Normal-vs-Grade 3 |
2.235000E-01 |
| Normal-vs-Grade 4 |
1.053820E-01 |
| Grade 1-vs-Grade 2 |
7.345500E-02 |
| Grade 1-vs-Grade 3 |
1.583480E-04 |
| Grade 1-vs-Grade 4 |
1.436020E-03 |
| Grade 2-vs-Grade 3 |
2.78160000000138E-06 |
| Grade 2-vs-Grade 4 |
3.248800E-04 |
| Grade 3-vs-Grade 4 |
3.984600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.457990E-02 |
| Normal-vs-ccB subtype |
5.056000E-01 |
| ccA subtype-vs-ccB subtype |
7.362600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.637000E-01 |
| Normal-vs-N1 |
4.456500E-02 |
| N0-vs-N1 |
8.581600E-02 |
|
|
